Academic literature on the topic 'Small bowel cancer'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Small bowel cancer.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Small bowel cancer"

1

Maglinte, Dean D. T., and Benedicto L. Reyes. "SMALL BOWEL CANCER." Radiologic Clinics of North America 35, no. 2 (1997): 361–80. http://dx.doi.org/10.1016/s0033-8389(22)00713-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Gore, Richard M. "SMALL BOWEL CANCER." Radiologic Clinics of North America 35, no. 2 (1997): 351–60. http://dx.doi.org/10.1016/s0033-8389(22)00712-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Buckley, Julie A., Bronwyn Jones, and Elliot K. Fishman. "SMALL BOWEL CANCER." Radiologic Clinics of North America 35, no. 2 (1997): 381–402. http://dx.doi.org/10.1016/s0033-8389(22)00714-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Chen, Emerson, and Gina Vaccaro. "Small Bowel Adenocarcinoma." Clinics in Colon and Rectal Surgery 31, no. 05 (2018): 267–77. http://dx.doi.org/10.1055/s-0038-1660482.

Full text
Abstract:
AbstractSmall bowel adenocarcinoma is a clinically and anatomically distinct gastrointestinal cancer that lacks prospective data to support its optimal management. Patients with inflammatory bowel disease and inherited conditions that cause gastrointestinal polyps are at especially high risk. Due to a lack of effective surveillance programs resulting in missed or delayed diagnoses only when symptoms develop, this disease is generally discovered at an advanced stage. Surgical resection is the only treatment modality with a chance of cure. Currently accepted treatment considerations are often ge
APA, Harvard, Vancouver, ISO, and other styles
5

Tsuboi, Akiyoshi, Yuji Urabe, Shiro Oka, et al. "Genomic analysis for the prediction of prognosis in small-bowel cancer." PLOS ONE 16, no. 5 (2021): e0241454. http://dx.doi.org/10.1371/journal.pone.0241454.

Full text
Abstract:
The current understanding of clinicopathological features and genomic variants of small-bowel cancer is limited, in part due to the rarity of the disease. However, understanding of these factors is necessary for the development of novel therapeutic agents for small-bowel cancer. Thus, we aimed to identify the clinicopathological features and genomic variants associated with its prognosis and recurrence. We retrospectively examined 24 consecutive patients with primary small-bowel cancer surgically treated between May 2005 and August 2018 and collected 29 tumor specimens. The 29 lesions were sub
APA, Harvard, Vancouver, ISO, and other styles
6

Faggiani, Ilaria, Ferdinando D’Amico, Federica Furfaro, et al. "Small Bowel Cancer in Crohn’s Disease." Cancers 16, no. 16 (2024): 2901. http://dx.doi.org/10.3390/cancers16162901.

Full text
Abstract:
Crohn’s disease (CD) is a chronic inflammatory bowel disease (IBD) that frequently affects the small bowel. Individuals diagnosed with CD are at increased risk of developing bowel cancer compared to the general population. Small bowel cancer is a rare but significant CD complication. Adenocarcinoma represents the most prevalent of these neoplasms, followed by neuroendocrine tumors and sarcomas. The primary risk factors identified are being of the male sex, disease duration, previous surgical intervention, perianal disease, and chronic inflammation. The precise etiology remains unclear. Another
APA, Harvard, Vancouver, ISO, and other styles
7

Pandya, Karan, Michael J. Overman, and Pat Gulhati. "Molecular Landscape of Small Bowel Adenocarcinoma." Cancers 14, no. 5 (2022): 1287. http://dx.doi.org/10.3390/cancers14051287.

Full text
Abstract:
Small bowel adenocarcinoma (SBA) is a rare malignancy, with lower incidence, later stage at diagnosis, and poor overall prognosis compared to other cancers of the gastrointestinal tract. Owing to the rarity of the disease along with the paucity of high-quality tissue samples and preclinical models, little is known about the molecular alterations characteristic of SBA. This is reflected by the fact that the clinical management of SBA is primarily extrapolated from colorectal cancer (CRC). Recent advances in genomic profiling have highlighted key differences between these tumors, establishing SB
APA, Harvard, Vancouver, ISO, and other styles
8

Ripley, Dianne, and Brian H. Weinerman. "Increased Incidence of Second Malignancies Associated with Small Bowel Adenocarcinoma." Canadian Journal of Gastroenterology 11, no. 1 (1997): 65–68. http://dx.doi.org/10.1155/1997/901217.

Full text
Abstract:
BACKGROUND:Some data suggest that there is an increased incidence of second malignancies associated with small bowel adenocarcinomas, but this has not been reviewed in the context of a tumour registry.OBJECTIVE:To review tumour registries based on population statistics to determine whether there is an increased incidence of second malignancies associated with small bowel adenocarcinomas.METHODS:The authors reviewed the tumour registries of two Canadian provinces (British Columbia and Manitoba) for small bowel adenocarcinoma to determine whether an increase in associated malignancies existed co
APA, Harvard, Vancouver, ISO, and other styles
9

GABOS, S., J. BERKEL, P. BAND, D. ROBSON, and H. WHITTAKER. "Small Bowel Cancer in Western Canada." International Journal of Epidemiology 22, no. 2 (1993): 198–206. http://dx.doi.org/10.1093/ije/22.2.198.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Assumpção, Paulo, André Khayat, Taíssa Araújo, et al. "The Small Bowel Cancer Incidence Enigma." Pathology & Oncology Research 26, no. 2 (2019): 635–39. http://dx.doi.org/10.1007/s12253-019-00682-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Small bowel cancer"

1

Lutgens, Ludy. "Citrulline a serological parameter for monitoring epithelial small bowel cancer treatment induced injury /." Maastricht : Maastricht : Universiteit Maastricht ; University Library, Maastricht University [Host], 2005. http://arno.unimaas.nl/show.cgi?fid=6497.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Wilson, David Scott. "Rational design and synthesis of drug delivery platforms for treating diseases associated with intestinal inflammation." Diss., Georgia Institute of Technology, 2011. http://hdl.handle.net/1853/45803.

Full text
Abstract:
Over 500 million people worldwide suffer from disease associated with intestinal inflammation, including gastric cancer, inflammatory bowel disease, h. pylori infections, and numerous viral and bacterial infections. Although potentially effective therapeutics exist for many of these pathologies, delivery challenges thwart their clinical viability. The objective of this work was to develop drug delivery platforms that could target toxic immunomodulatory therapeutics to diseased intestinal tissues. To meet this objective, we developed an oral delivery vehicle for siRNA and an NF-κB inhibiting na
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Small bowel cancer"

1

Atlas of Inflammatory Bowel Disease-Associated Intestinal Cancer: Examining the Macroscopic Images of Small and Large Intestine. Springer, 2022.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Atlas of Inflammatory Bowel Disease-Associated Intestinal Cancer: Examining the Macroscopic Images of Small and Large Intestine. Springer, 2023.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Keshav, Satish, and Alexandra Kent. Chronic diarrhoea. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0029.

Full text
Abstract:
Four to five per cent of the Western population suffers from chronic diarrhoea (defined as the passage of >3 stools per day, for >4 weeks), with irritable bowel syndrome (IBS) being the commonest cause in 20–40-year-old patients. It is the commonest reason for referral to secondary care gastroenterology clinics. The list of possible causes of chronic diarrhoea is long but, in the absence of rectal bleeding, loss of weight, or abnormal blood tests, it is unlikely to be due to a serious illness. Laboratory investigations should include serum glucose, electrolytes, renal and liver tests, fu
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Small bowel cancer"

1

Metzger, U. "Small Bowel Cancer." In Surgical Oncology. Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-72646-0_55.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Gleason, David, Kimberly E. Miller-Hammond, and John F. Gibbs. "Small Bowel Cancer." In Surgical Oncology. Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-1423-4_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Colloca, Giuseppe A., and Antonella Venturino. "Small bowel adenocarcinoma." In The Prognosis of Metastatic Gastrointestinal Cancer. CRC Press, 2024. http://dx.doi.org/10.1201/9781032703350-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

McWilliams, Robert R., Thomas C. Smyrk, and Axel Grothey. "Cancer of the Small Bowel." In Textbook of Uncommon Cancer. John Wiley & Sons, Ltd, 2006. http://dx.doi.org/10.1002/0470030542.ch34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Zerunian, Marta, Gisella Guido, Domenico De Santis, Damiano Caruso, and Andrea Laghi. "Small Bowel and Colon Cancer." In Multimodality Imaging and Intervention in Oncology. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-28524-0_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Raghav, Kanwal, Matthew H. G. Katz, and Michael J. Overman. "Cancers of the Small Bowel." In Textbook of Uncommon Cancer. John Wiley & Sons, Inc., 2012. http://dx.doi.org/10.1002/9781118464557.ch31.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Knab, L. Mark, and Anthony Yang. "Gastric and Small Bowel Tumors." In Cancer Treatment and Research. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-34244-3_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Matsui, Toshiyuki. "Malignancies: Colitic Cancer and Small Bowel Cancer (Intestinal Cancer) in IBD." In Atlas of Inflammatory Bowel Diseases. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-39423-2_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Raghav, Kanwal, Matthew H. G. Katz, and Michael J. Overman. "Uncommon Cancers of the Small Bowel." In Textbook of Uncommon Cancer. John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781119196235.ch28.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Futami, Kitaro, Hiroshi Tanabe, Keisuke Kawasaki, Koji Ikegami, Minako Fujiwara, and Takayuki Matsumoto. "Small Intestinal Cancer: 5 Cases." In Atlas of Inflammatory Bowel Disease-Associated Intestinal Cancer. Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-3413-1_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Small bowel cancer"

1

Zhao, Quan, Hushan Zhang, Zhuyun Lei, Jianing Sheng, and Dun Xiong. "Abstract 2184: Gene characteristics of Chinese patients with small bowel cancer." In Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.am2021-2184.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Seo, Y. David, Russell G. Witt, Samuel Cass, et al. "Cancer testis antigen and interleukin expression correlates with survival in small bowel neuroendocrine tumors." In Leading Edge of Cancer Research Symposium. The University of Texas at MD Anderson Cancer Center, 2022. http://dx.doi.org/10.52519/00084.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Bokhua, D., C. E. Goerdt, V. Auletta, I. Cepraga, A. Kather, and I. B. Runnebaum. "Pre-debulking assessment of critical tumor spread to small bowel using the peritoneal cancer index (PCI) in primary advanced ovarian cancer." In 65. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe e. V. Georg Thieme Verlag KG, 2024. http://dx.doi.org/10.1055/s-0044-1790647.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ahmad, Ahmir, Ana Wilson, Angad Dhillon, et al. "PTU-20 No surveillance interval change with optical diagnosis of small polyps during bowel cancer screening colonoscopy." In Abstracts of the BSG Annual Meeting, 8–12 November 2021. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2021. http://dx.doi.org/10.1136/gutjnl-2021-bsg.93.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bisht, Jyoti, Ravi Kant, Meenu Gupta, et al. "Dosimetric evaluation of sigmoidal and bowel doses in the treatment of carcinoma of cervix using CT based volumetric imaging technique." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685397.

Full text
Abstract:
Purpose: Radiation therapy is the main stray for the treatment of the cervical cancer. Normal organs such as bladder, rectum, sigmoid colon and bowel loops also get significant dose during treatment of carcinoma of cervix which often results late toxicity. The purpose of this study is evaluate CT image based volumetric doses of organ at risk and correlate the doses with the toxicity profile observed in cancer patients. Materials and Methods: Sixty high dose rate intracavitary brachytherapy applications were performed in thirty patients of carcinoma of cervix. External beam therapy was planned
APA, Harvard, Vancouver, ISO, and other styles
6

Miladinović, Tatjana, Aleksandar Miladinović, Nina Pavlović, Dragoslav Nikezić, and Dragana Krstić. "DOSIMETRIC COMPARISON OF VMAT AND 3D CONFORMAL RADIOTHERAPY IN PREOPERATIVE RECTAL CANCER." In 1st INTERNATIONAL Conference on Chemo and BioInformatics. Institute for Information Technologies, University of Kragujevac, 2021. http://dx.doi.org/10.46793/iccbi21.181m.

Full text
Abstract:
The standard procedure in treating rectum cancer is surgical intervention, but presurgical chemotherapy and radiotherapy lead to a lower rate of localized recidives. Our study compared the results obtained by two techniques of radiation treatment planning (RTP) in radiotherapy, which patients received in the preoperative course of rectum cancer treatment, Volumetric Modulated Arc Therapy (VMAT) and field-in-field three-dimensional conformal radiotherapy (FIF 3D-CRT). We analyzed better coverage of the planning target volume (PTV) and better protection of organs from risk (OAR): bladder, bowel,
APA, Harvard, Vancouver, ISO, and other styles
7

Abdulelah, Ahmed, Zaid Abdulelah, Mohammad Alqaisieh, Abdulrahman Alhajahjeh, Ahmad Ghazzawi, and Amer Khatib. "O15 Epidemiological analysis and overall survival of small bowel cancer in a developing middle eastern country over 18 years." In BSG LIVE’24, 17-20 June 2024, ICC Birmingham. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2024. http://dx.doi.org/10.1136/gutjnl-2024-bsg.15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Rajanbabu, Anupama, and Kiran Bagul. "A prospective study evaluating preoperative (clinical, imaging) and intraoperative predictors of suboptimal debulking in advanced epithelial ovarian cancer." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685288.

Full text
Abstract:
Introduction: In advanced epithelial ovarian cancer, there is a survival benefit for patients who achieve optimalcytoreduction. Suboptimallycytoreduced patients are at risk of the increased morbidity of a surgery without associated survival benefit. Predicting which patients can undergo optimal cytoreduction represents a critical decision-making point. Present study analyses the predictors, pre operative (clinical and radiologic) and intraoperative of suboptimal debulking. Methods: This was a prospective observational study conducted at Amrita Institute of Medical Sciences from March 2013 to M
APA, Harvard, Vancouver, ISO, and other styles
9

Al-Shakhshir, Sarah, Nadir Abbas, Sean Morris, et al. "P316 Small duct primary sclerosing cholangitis is not associated with heightened risk of colorectal cancer compared to inflammatory bowel disease alone." In BSG LIVE’24, 17-20 June 2024, ICC Birmingham. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2024. http://dx.doi.org/10.1136/gutjnl-2024-bsg.398.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Batra, Ankit. "Clinical comparison of toxicity pattern of two linear quadratic model-baesd fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685255.

Full text
Abstract:
Introduction: Carcinoma cervix is the fourth (GLOBACON 2012) most common cancer among women worldwide, and the main cancer affecting women in Sub-Saharan Africa, Central America and south-central Asia. In India, approx. 1,23,000 (GLOBACON 2012) new cases of carcinoma cervix are diagnosed each year. Brachytherapy is an integral part of treatment of cancer cervix. In the context of a developing country like us where maximum utilization of the resource is of prime importance to provide treatment to the large patient cohort, shortening the treatment duration and number of fractions always increase
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Small bowel cancer"

1

Dahm, Philipp, Michelle Brasure, Elizabeth Ester, et al. Therapies for Clinically Localized Prostate Cancer. Agency for Healthcare Research and Quality (AHRQ), 2020. http://dx.doi.org/10.23970/ahrqepccer230.

Full text
Abstract:
Objective. To update findings from previous Agency for Healthcare Research and Quality (AHRQ)- and American Urological Association (AUA) funded reviews evaluating therapies for clinically localized prostate cancer (CLPC). Sources. Bibliographic databases (2013–January 2020); ClinicalTrials.gov; systematic reviews Methods. Controlled studies of CLPC treatments with duration ≥5 years for mortality and metastases and ≥1 year for quality of life and harms. One investigator rated risk of bias (RoB), extracted data, and assessed certainty of evidence; a second checked accuracy. We analyzed English-l
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!